Stock image. 

West Palm Beach, FL—A Florida biotech company settled its malpractice claim against legal giant Greenberg Traurig, one day after the trial’s judge issued directed verdicts limiting the law firm’s defenses but slashing the company’s original $700 million-plus damage claim. Dyadic International v. Greenberg Traurig, 2009CA010680. 

Mark Emalfarb details emailed allegations at the heart of Dyadic International's $700-plus million legal malpractice trial against Greenberg Traurig.  

West Palm Beach, FL—The CEO of a Florida biotech company told jurors last week he felt he was made into a scapegoat during a rush to judgment that allegedly cost his company $700 million in lost business, as trial continued in the company’s malpractice suit against legal giant Greenberg Traurig.  Dyadic Inc. v. Greenberg Traurig, 2009CA010680.

Andrew Balog testifies at trial over allegations his firm, Greenberg Traurig, committed malpractice in representing Florida-based biotech firm Dyadic International. 

West Palm Beach, FL—A Greenberg Traurig attorney this week defended his recommendation that a Florida biotech company halt trading of its stock because of anonymous accusations against its subsidiary, as trial continued over the company’s malpractice claim against the law firm. Dyadic Inc. v. Greenberg Traurig, 2009CA010680.

 Stock image. 

West Palm Beach, FL— Bad legal advice slashed a biotech company’s value by more than $185 million and cost it more than $700 million in lost business, an attorney for the company said Wednesday, as trial opened against legal giant Greenberg Traurig. Dyadic Inc. v. Greenberg Traurig, 2009CA010680.